TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center > Enterprise Dynamic >
Enterprise Dynamic
Jiuzhang Biotech has been granted 13 oversea invention patents
Date:2019-09-04

At the end of 2017, the Company had been granted the patent applied in the United States, indicating that Jiuzhang Biotech had made important progress in the field of foreign intellectual property protection.


USA:

1. “A Chlorogenic Acid Powder for Injection and its Preparation Method”, USA authorization number: US9918956 B2.


2. “Use of Chlorogenic Acid in the Preparation of Drugs for Oligodendroglioma”, USA patent number: US10004713 B2.


3. “Use of Chlorogenic Acid in the Preparation of Drugs for Psoriasis”, USA patent number: US9884036 B2.


4. “Use of Chlorogenic Acid in the Preparation of Drugs for Lupus Erythematosus”, USA authorization number: US10058525/B2.


5. “A Preparation Method for Medicinal Chlorogenic Acid”, USA authorization number: US10189769 B2;


6. “A Chlorogenic Acid Crystal Form and its Preparation Method”, USA authorization number: US10246401.


7. “A Drug Composition and its Preparation Method and Use”, USA authorization number: US10238702.


8.”Use of Chlorogenic Acid in the Preparation of Melanoma and Drugs for Melanoma”, USA Authorization number: US10265289.


9. “A Preparation Containing Chlorogenic Acid Crystals and its Use”, USA Application number: 15/528,996.


Japan:

1. “A Chlorogenic Acid Raw Material or Drug Substance and its Preparation Method and Quality Test method”, Japanese authorization number: 6379286.


2. “A Preparation Method for Medicinal Chlorogenic Acid”, Japanese authorization number: 6488379.


3.”A method for extracting chlorogenic acid from Folium Eucommiae leaves”, Japan Authorization number: 6473803.


Korea:

1. “A Chlorogenic Acid Crystal Form and its Preparation Method”, Korea application number: 10-2016-7026983.


The above information was updated in June 2019.



Prev:Jiuzhang Biotech Data Presentation on the Phase I Clinical Trial on the Safety, Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Treating Advanced Cerebral Glioma
Next:Phase I clinical trial of chlorogenic acid for injection showed efficacy beyond the investigator's estimation